FDA Import Refusal F23-9340161-7/40002/1 — Lilly S.A.
The FDA refused shipment F23-9340161-7/40002/1 from Lilly S.A. (Spain) on September 3, 2025. The refused product falls under Drugs and Biologics — BARICITINIB (ANTI-RHEUMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- September 3, 2025
- Country
- Spain
- Product Category
- Drugs and Biologics
- Product Code
- 62QCY05 BARICITINIB (ANTI-RHEUMATIC)
- Charges
- 75